0001775697-20-000770.txt : 20200522 0001775697-20-000770.hdr.sgml : 20200522 20200522072744 ACCESSION NUMBER: 0001775697-20-000770 CONFORMED SUBMISSION TYPE: NPORT-P PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20200331 FILED AS OF DATE: 20200522 PERIOD START: 20201231 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BNY Mellon Large Cap Securities Fund, Inc. CENTRAL INDEX KEY: 0000030146 IRS NUMBER: 136021175 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: NPORT-P SEC ACT: 1940 Act SEC FILE NUMBER: 811-00523 FILM NUMBER: 20903648 BUSINESS ADDRESS: STREET 1: C/O BNY MELLON INVESTMENT ADVISER, INC. STREET 2: 240 GREENWICH STREET CITY: NEW YORK STATE: NY ZIP: 10286 BUSINESS PHONE: 2129226400 MAIL ADDRESS: STREET 1: C/O BNY MELLON INVESTMENT ADVISER, INC. STREET 2: 240 GREENWICH STREET CITY: NEW YORK STATE: NY ZIP: 10286 FORMER COMPANY: FORMER CONFORMED NAME: DREYFUS FUND INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: NESBETT FUND INC DATE OF NAME CHANGE: 19680607 0000030146 S000000068 BNY Mellon Large Cap Securities Fund, Inc. C000000105 BNY Mellon Large Cap Securities Fund, Inc. DREVX NPORT-P 1 primary_doc.xml NPORT-P false 0000030146 XXXXXXXX S000000068 C000000105 BNY Mellon Large Cap Securities Fund, Inc. 811-00523 0000030146 549300BH6NJF63HZ1E81 240 Greenwich Street New York 10286 212 495 1784 BNY Mellon Large Cap Securities Fund, Inc. S000000068 549300BH6NJF63HZ1E81 2020-12-31 2020-03-31 N 21206786.8 44621.48 1062167452.28 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 UST ADOBE INC FU4LY2G4933NH2E1CP29 ADOBE INC 00724F101 53286.00 NS USD 16957736.64 1.5965219611652 Long EC CORP US N 1 N N N BECTON DICKINSON AND CO ICE2EP6D98PQUILVRZ91 BECTON DICKINSON AND CO 075887109 72689.00 NS USD 16701751.53 1.572421701884 Long EC CORP US N 1 N N N COSTCO WHOLESALE CORP 29DX7H14B9S6O3FD6V18 COSTCO WHOLESALE CORP 22160K105 74132.00 NS USD 21137257.16 1.9900117551736 Long EC CORP US N 1 N N N AMETEK INC 549300WZDEF9KKE40E98 AMETEK INC 031100100 196651.00 NS USD 14162805.02 1.3333872158856 Long EC CORP US N 1 N N N APPLE INC HWUPKR0MPOU8FGXBT394 APPLE INC 037833100 262555.00 NS USD 66765110.95 6.2857424981988 Long EC CORP US N 1 N N N CUMMINS INC ZUNI8PYC725B6H8JU438 CUMMINS INC 231021106 140096.00 NS USD 18957790.72 1.7848212802327 Long EC CORP US N 1 N N N DANAHER CORP S4BKK9OTCEWQ3YHPFM11 DANAHER CORP 235851102 137647.00 NS USD 19051721.27 1.7936645704125 Long EC CORP US N 1 N N N MCDONALD'S CORP UE2136O97NLB5BYP9H04 MCDONALD'S CORP 580135101 159360.00 NS USD 26350176.00 2.4807930184113 Long EC CORP US N 1 N N N MICROSOFT CORP INR2EJN1ERAN0W5ZP974 MICROSOFT CORP 594918104 486190.00 NS USD 76677024.9 7.2189205887836 Long EC CORP US N 1 N N N PEPSICO INC FJSUNZKFNQ5YPJ5OT455 PEPSICO INC 713448108 261886.00 NS USD 31452508.6 2.9611629063275 Long EC CORP US N 1 N N N JPMORGAN CHASE & CO 8I5DZWZKVSZI1NUHU748 JPMORGAN CHASE & CO 46625H100 310798.00 NS USD 27981143.94 2.6343439426558 Long EC CORP US N 1 N N N VERTEX PHARMACEUTICALS INC 54930015RAQRRZ5ZGJ91 VERTEX PHARMACEUTICALS INC 92532F100 87080.00 NS USD 20720686.00 1.950792782769 Long EC CORP US N 1 N N N WALMART INC Y87794H0US1R65VBXU25 WALMART INC 931142103 198951.00 NS USD 22604812.62 2.1281778660678 Long EC CORP US N 1 N N N QUALCOMM INC H1J8DDZKZP6H7RWC0H53 QUALCOMM INC 747525103 104239.00 NS USD 7051768.35 0.663903637309 Long EC CORP US N 1 N N N US BANCORP N1GZ7BBF3NP8GI976H15 US BANCORP 902973304 396118.00 NS USD 13646265.1 1.2847564732573 Long EC CORP US N 1 N N N ABBVIE INC FR5LCKFTG8054YNNRU85 ABBVIE INC 00287Y109 280528.00 NS USD 21373428.32 2.0122465882494 Long EC CORP US N 1 N N N MERCK & CO INC 4YV9Y5M8S0BRK1RP0397 MERCK & CO INC 58933Y105 360622.00 NS USD 27746256.68 2.6122299850594 Long EC CORP US N 1 N N N NVIDIA CORP 549300S4KLFTLO7GSQ80 NVIDIA CORP 67066G104 111767.00 NS USD 29461781.2 2.7737416672633 Long EC CORP US N 1 N N N AMERICAN INTERNATIONAL GROUP INC ODVCVCQG2BP6VHV36M30 AMERICAN INTERNATIONAL GROUP INC 026874784 657503.00 NS USD 15944447.75 1.5011237367304 Long EC CORP US N 1 N N N VALERO ENERGY CORP 549300XTO5VR8SKV1V74 VALERO ENERGY CORP 91913Y100 318404.00 NS USD 14442805.44 1.3597484472902 Long EC CORP US N 1 N N N ROCKWELL AUTOMATION INC VH3R4HHBHH12O0EXZJ88 ROCKWELL AUTOMATION INC 773903109 78051.00 NS USD 11778676.41 1.1089283883361 Long EC CORP US N 1 N N N BOSTON SCIENTIFIC CORP Y6ZDD9FP4P8JSSJMW954 BOSTON SCIENTIFIC CORP 101137107 584877.00 NS USD 19084536.51 1.796754030547 Long EC CORP US N 1 N N N PPL CORP 9N3UAJSNOUXFKQLF3V18 PPL CORP 69351T106 525105.00 NS USD 12959591.4 1.2201081262828 Long EC CORP US N 1 N N N BIOGEN INC W8J5WZB5IY3K0NDQT671 BIOGEN INC 09062X103 45421.00 NS USD 14370295.98 1.3529218909083 Long EC CORP US N 1 N N N UNION PACIFIC CORP 549300LMMRSZZCZ8CL11 UNION PACIFIC CORP 907818108 147665.00 NS USD 20826671.6 1.9607710211129 Long EC CORP US N 1 N N N AMAZON.COM INC ZXTILKJKG63JELOEG630 AMAZON.COM INC 023135106 34062.00 NS USD 66411362.64 6.2524381158022 Long EC CORP US N 1 N N N PROGRESSIVE CORP/THE 529900TACNVLY9DCR586 PROGRESSIVE CORP/THE 743315103 214176.00 NS USD 15814755.84 1.4889136177212 Long EC CORP US N 1 N N N CBOE GLOBAL MARKETS INC 529900RLNSGA90UPEH54 CBOE GLOBAL MARKETS INC 12503M108 191308.00 NS USD 17074239.00 1.6074903221096 Long EC CORP US N 1 N N N FMC CORP CKDHZ2X64EEBQCSP7013 FMC CORP 302491303 264680.00 NS USD 21621709.2 2.035621516512 Long EC CORP US N 1 N N N APPLIED MATERIALS INC 41BNNE1AFPNAZELZ6K07 APPLIED MATERIALS INC 038222105 301345.00 NS USD 13807627.9 1.2999483151513 Long EC CORP US N 1 N N N NEXTERA ENERGY CAPITAL UMI46YPGBLUE4VGNNT48 NEXTERA ENERGY INC 65339F101 104218.00 NS USD 25076935.16 2.3609210681584 Long EC CORP US N 1 N N N SERVICENOW INC 549300HJTQM36M0E1G39 SERVICENOW INC 81762P102 79160.00 NS USD 22685672.8 2.1357906186358 Long EC CORP US N 1 N N N ROPER TECHNOLOGIES INC 54930003T4SXCIWVXY35 ROPER TECHNOLOGIES INC 776696106 69537.00 NS USD 21682331.97 2.0413289753378 Long EC CORP US N 1 N N N ANTHEM INC 8MYN82XMYQH89CTMTH67 ANTHEM INC 036752103 71304.00 NS USD 16188860.16 1.5241344597078 Long EC CORP US N 1 N N N ALPHABET INC 5493006MHB84DD0ZWV18 ALPHABET INC 02079K107 40105.00 NS USD 46634495.05 4.390503112282 Long EC CORP US N 1 N N N MEDTRONIC PLC 549300GX3ZBSQWUXY261 MEDTRONIC PLC N/A 172962.00 NS USD 15597713.16 1.4684796758287 Long EC CORP IE N 1 N N N S&P GLOBAL INC Y6X4K52KMJMZE7I7MY94 S&P GLOBAL INC 78409V104 54922.00 NS USD 13458636.1 1.2670917444429 Long EC CORP US N 1 N N N TRANE TECHNOLOGIES PLC 549300BURLR9SLYY2705 TRANE TECHNOLOGIES PLC N/A 150554.00 NS USD 12434254.86 1.1706492072703 Long EC CORP IE N 1 N N N INGERSOLL RAND INC 5299004C02FMZCUOIR50 INGERSOLL RAND INC 45687V106 132848.00 NS USD 3294630.4 0.3101799431839 Long EC CORP US N 1 N N N VISA INC 549300JZ4OKEHW3DPJ59 VISA INC 92826C839 257334.00 NS USD 41461654.08 3.9034950648318 Long EC CORP US N 1 N N RAYTHEON CO YR6K3WJN0KKLUPZSNL57 RAYTHEON CO 755111507 116924.00 NS USD 15334582.6 1.4437066930532 Long EC CORP US N 1 N N N ZOETIS INC 549300HD9Q1LOC9KLJ48 ZOETIS INC 98978V103 182076.00 NS USD 21428524.44 2.0174337289287 Long EC CORP US N 1 N N N VERIZON COMMUNICATIONS INC 2S72QS2UO2OESLG6Y829 VERIZON COMMUNICATIONS INC 92343V104 439613.00 NS USD 23620406.49 2.223793097717 Long EC CORP US N 1 N N N LOWE'S COS INC WAFCR4OKGSC504WU3E95 LOWE'S COS INC 548661107 176382.00 NS USD 15177671.1 1.4289339282069 Long EC CORP US N 1 N N N SALESFORCE.COM INC RCGZFPDMRW58VJ54VR07 SALESFORCE.COM INC 79466L302 183860.00 NS USD 26472162.8 2.4922777235525 Long EC CORP US N 1 N N N PAYPAL HOLDINGS INC 5493005X2GO78EFZ3E94 PAYPAL HOLDINGS INC 70450Y103 208281.00 NS USD 19940822.94 1.877370926514 Long EC CORP US N 1 N N N DREYFUS INSTITUTIONAL PREFERRED GOVERNMENT MONEY MARKET N/A Dreyfus Institutional Preferred Government Plus Money Market Fund N/A 8302495.73 OU Other Units USD 8302495.73 0.7816560102814 Long STIV RF US N 1 2099-12-01 Variable 0.400386 N N N N N N 2020-05-21 BNY Mellon Advantage Funds, Inc. James Windels James Windels Fund Treasurer XXXX NPORT-EX 2 c10625bnymellonla-march20201.htm Untitled Document

STATEMENT OF INVESTMENTS
BNY Mellon Large Cap Securities Fund, Inc.

March 31, 2020 (Unaudited)

        
 

Description

   

Shares

 

Value ($)

 

Common Stocks - 100.0%

     

Banks - 3.9%

     

JPMorgan Chase & Co.

   

310,798

 

27,981,144

 

U.S. Bancorp

   

396,118

 

13,646,265

 
    

41,627,409

 

Capital Goods - 9.2%

     

AMETEK

   

196,651

 

14,162,805

 

Cummins

   

140,096

 

18,957,791

 

Ingersoll Rand

   

132,848

a

3,294,630

 

Raytheon

   

116,924

 

15,334,583

 

Rockwell Automation

   

78,051

 

11,778,676

 

Roper Technologies

   

69,537

 

21,682,332

 

Trane Technologies

   

150,554

 

12,434,255

 
    

97,645,072

 

Consumer Services - 2.5%

     

McDonald's

   

159,360

 

26,350,176

 

Diversified Financials - 4.2%

     

Cboe Global Markets

   

191,308

 

17,074,239

 

S&P Global

   

54,922

 

13,458,636

 

The Goldman Sachs Group

   

88,561

 

13,690,645

 
    

44,223,520

 

Energy - 1.4%

     

Valero Energy

   

318,404

 

14,442,805

 

Food & Staples Retailing - 4.1%

     

Costco Wholesale

   

74,132

 

21,137,257

 

Walmart

   

198,951

 

22,604,813

 
    

43,742,070

 

Food, Beverage & Tobacco - 3.0%

     

PepsiCo

   

261,886

 

31,452,509

 

Health Care Equipment & Services - 8.1%

     

Anthem

   

71,304

 

16,188,860

 

Becton Dickinson & Co.

   

72,689

 

16,701,752

 

Boston Scientific

   

584,877

a

19,084,537

 

Danaher

   

137,647

 

19,051,721

 

Medtronic

   

172,962

 

15,597,713

 
    

86,624,583

 

Insurance - 3.0%

     

American International Group

   

657,503

 

15,944,448

 

The Progressive

   

214,176

 

15,814,756

 
    

31,759,204

 


STATEMENT OF INVESTMENTS (Unaudited) (continued)

        
 

Description

   

Shares

 

Value ($)

 

Common Stocks - 100.0% (continued)

     

Materials - 2.0%

     

FMC

   

264,680

 

21,621,709

 

Media & Entertainment - 7.0%

     

Alphabet, Cl. C

   

40,105

a

46,634,495

 

Facebook, Cl. A

   

163,813

a

27,324,008

 
    

73,958,503

 

Pharmaceuticals Biotechnology & Life Sciences - 9.9%

     

AbbVie

   

280,528

 

21,373,428

 

Biogen

   

45,421

a

14,370,296

 

Merck & Co.

   

360,622

 

27,746,257

 

Vertex Pharmaceuticals

   

87,080

a

20,720,686

 

Zoetis

   

182,076

 

21,428,524

 
    

105,639,191

 

Retailing - 7.3%

     

Amazon.com

   

31,836

a

62,071,286

 

Lowe's

   

176,382

 

15,177,671

 
    

77,248,957

 

Semiconductors & Semiconductor Equipment - 4.5%

     

Applied Materials

   

413,807

 

18,960,637

 

NVIDIA

   

111,767

 

29,461,781

 
    

48,422,418

 

Software & Services - 18.3%

     

Adobe

   

53,286

a

16,957,737

 

Microsoft

   

486,190

 

76,677,025

 

PayPal Holdings

   

208,281

a

19,940,823

 

salesforce.com

   

152,387

a

21,940,680

 

ServiceNow

   

60,750

a

17,409,735

 

Visa, Cl. A

   

257,334

b

41,461,654

 
    

194,387,654

 

Technology Hardware & Equipment - 6.0%

     

Apple

   

251,781

 

64,025,390

 

Transportation - 2.0%

     

Union Pacific

   

147,665

 

20,826,672

 

Utilities - 3.6%

     

NextEra Energy

   

104,218

 

25,076,935

 

PPL

   

525,105

 

12,959,591

 
    

38,036,526

 

Total Common Stocks (cost $878,478,155)

   

1,062,034,368

 
  

1-Day
Yield (%)

     

Investment Companies - .8%

     

Registered Investment Companies - .8%

     

Dreyfus Institutional Preferred Government Plus Money Market Fund
(cost $8,302,496)

 

0.40

 

8,302,496

c

8,302,496

 


      

Total Investments (cost $886,780,651)

 

100.8%

 

1,070,336,864

 

Liabilities, Less Cash and Receivables

 

(.8%)

 

(8,169,412)

 

Net Assets

 

100.0%

 

1,062,167,452

 

a Non-income producing security.

b Security, or portion thereof, on loan. At March 31, 2020, the value of the fund’s securities on loan was $40,645,904 and the value of the collateral was $42,610,156, consisting of U.S. Government & Agency securities.

c Investment in affiliated issuer. The investment objective of this investment company is publicly available and can be found within the investment company’s prospectus.


STATEMENT OF INVESTMENTS
BNY Mellon Large Cap Securities Fund, Inc.

March 31, 2020 (Unaudited)

The following is a summary of the inputs used as of March 31, 2020 in valuing the fund’s investments:

     
 

Level 1 - Unadjusted Quoted Prices

Level 2 - Other Significant Observable Inputs

Level 3 -Significant Unobservable Inputs

Total

Assets ($)

    

Investments in Securities:

  

Equity Securities—Common Stocks

1,062,034,368

-

-

1,062,034,368

Investment Companies

8,302,496

-

-

8,302,496

     

See Statement of Investments for additional detailed categorizations, if any.


NOTES

The Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) is the exclusive reference of authoritative U.S. generally accepted accounting principles (“GAAP”) recognized by the FASB to be applied by nongovernmental entities. Rules and interpretive releases of the Securities and Exchange Commission (“SEC”) under authority of federal laws are also sources of authoritative GAAP for SEC registrants. The fund is an investment company and applies the accounting and reporting guidance of the FASB ASC Topic 946 Financial Services-Investment Companies. The fund’s financial statements are prepared in accordance with GAAP, which may require the use of management estimates and assumptions. Actual results could differ from those estimates.

The fair value of a financial instrument is the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (i.e., the exit price). GAAP establishes a fair value hierarchy that prioritizes the inputs of valuation techniques used to measure fair value. This hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements).

Additionally, GAAP provides guidance on determining whether the volume and activity in a market has decreased significantly and whether such a decrease in activity results in transactions that are not orderly. GAAP requires enhanced disclosures around valuation inputs and techniques used during annual and interim periods.

Various inputs are used in determining the value of the fund’s investments relating to fair value measurements. These inputs are summarized in the three broad levels listed below:

Level 1—unadjusted quoted prices in active markets for identical investments.

Level 2—other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, credit risk, etc.).

Level 3—significant unobservable inputs (including the fund’s own assumptions in determining the fair value of investments).

The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.

Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy. Valuation techniques used to value the fund’s investments are as follows:

Investments in equity securities are valued at the last sales price on the securities exchange or national securities market on which such securities are primarily traded. Securities listed on the National Market System for which market quotations are available are valued at the official closing price or, if there is no official closing price that day, at the last sales price. For open short positions, asked prices are used for valuation


NOTES

purposes. Bid price is used when no asked price is available. Registered investment companies that are not traded on an exchange are valued at their net asset value. All of the preceding securities are generally categorized within Level 1 of the fair value hierarchy.

Securities not listed on an exchange or the national securities market, or securities for which there were no transactions, are valued at the average of the most recent bid and asked prices. U.S. Treasury Bills are valued at the mean price between quoted bid prices and asked prices by an independent pricing service (the “Service”) approved by the Board Members (“Board”). These securities are generally categorized within Level 2 of the fair value hierarchy.

The Service’s procedures are reviewed by BNY Mellon under the general supervision of the Board.

Fair valuing of securities may be determined with the assistance of a pricing service using calculations based on indices of domestic securities and other appropriate indicators, such as prices of relevant American Depository Receipts and futures. Utilizing these techniques may result in transfers between Level 1 and Level 2 of the fair value hierarchy.

When market quotations or official closing prices are not readily available, or are determined not to accurately reflect fair value, such as when the value of a security has been significantly affected by events after the close of the exchange or market on which the security is principally traded (for example, a foreign exchange or market), but before the fund calculates its net asset value, the fund may value these investments at fair value as determined in accordance with the procedures approved by the Board. Certain factors may be considered when fair valuing investments such as: fundamental analytical data, the nature and duration of restrictions on disposition, an evaluation of the forces that influence the market in which the securities are purchased and sold, and public trading in similar securities of the issuer or comparable issuers. These securities are either categorized within Level 2 or 3 of the fair value hierarchy depending on the relevant inputs used.

For securities where observable inputs are limited, assumptions about market activity and risk are used and such securities are generally categorized within Level 3 of the fair value hierarchy.

Pursuant to a securities lending agreement with The Bank of New York Mellon, a subsidiary of BNY Mellon and an affiliate of BNY Mellon Investment Adviser, Inc., the fund may lend securities to qualified institutions. It is the fund’s policy that, at origination, all loans are secured by collateral of at least 102% of the value of U.S. securities loaned and 105% of the value of foreign securities loaned. Collateral equivalent to at least 100% of the market value of securities on loan is maintained at all times. Collateral is either in the form of cash, which can be invested in certain money market mutual funds managed by BNY Mellon Investment Adviser Inc., or U.S. Government and Agency securities. The fund is entitled to receive all dividends, interest and distributions on securities loaned, in addition to income earned as a


NOTES

result of the lending transaction. Should a borrower fail to return the securities in a timely manner, The Bank of New York Mellon is required to replace the securities for the benefit of the fund or credit the fund with the market value of the unreturned securities and is subrogated to the fund’s rights against the borrower and the collateral. Additionally, the contractual maturity of security lending transactions are on an overnight and continuous basis.

At March 31, 2020, accumulated net unrealized appreciation on investments was $183,556,213, consisting of $261,930,372 gross unrealized appreciation and $78,374,159 gross unrealized depreciation.

At March 31, 2020, the cost of investments for federal income tax purposes was substantially the same as the cost for financial reporting purposes (see the Statement of Investments).

Additional investment related disclosures are hereby incorporated by reference to the annual and semi-annual reports previously filed with the SEC on Form N-CSR.